TypeSafe AI
Developer infrastructure that turns unstructured inputs into typed decisions and probability scores for automated software workflows.
$870MSeries A
ParticipantD
DCVC
Activity from announced rounds
All recorded activity
DCVC is an investment firm identified by TypeSafe AI as an existing investor and by its own communications as a backer of Shennon Biotechnologies.
Recorded funding activity
TypeSafe turns unstructured inputs into typed decisions and probability scores for automated software. Shennon develops T-cell engager therapies for solid tumors. Separate TypeSafe financings remain separate events under one investor history.
Sources
- Rounds participated in
- 13
- Confirmed lead rounds
- 2 8 roles undisclosed
- New companies
- 12 First participation on record · 1 follow-on
- Funding in participating rounds
- $1.8B 11 disclosed · full round size, not this investor’s share
By stage
By primary sector
1 more
Defense tech1
By country
Rounds
13 in all activityUniversal Quantum
Modular trapped-ion quantum computers built by connecting small quantum chips.
>$100MSeries A
LeadRainmaker
Rainmaker develops cloud-seeding technology and atmospheric research tools to increase freshwater supply.
$100MSeries B
ParticipantTypeSafe AI
Developer infrastructure that turns unstructured inputs into typed decisions and probability scores for automated software workflows.
$40MSeed
LeadShennon Biotechnologies
Shennon Biotechnologies is developing precision T-cell engager immunotherapies for solid tumors.
$12MFunding
ParticipantCallosum
Software infrastructure allowing AI workloads to run across different chips and models
$100MSeed
Role not disclosedSabanto
Sabanto develops autonomous retrofit technology for agricultural equipment.
UndisclosedSeries B
Role not disclosedAtom Computing
Develops large-scale neutral-atom quantum computers for fault-tolerant commercial and government applications
$100MSeries C
Role not disclosedQuantum Motion
Builds utility-scale quantum computers using industry-standard silicon transistors
$160MSeries C
Role not disclosedKanvas Biosciences
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
$48MSeries A
Role not disclosedHalter
Develops GPS-enabled cattle collars using sensors, software and AI.
$220MSeries E
Role not disclosedChariot Defense
Chariot Defense develops power-distribution systems for military use.
$34MSeries A
Role not disclosedProxima
Develops AI-driven drug discovery for proximity therapeutics
$80MUndisclosed
Role not disclosed